QQQ $ 491.58 $ -0.16 (-0.03 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 92.08 $ 0.00 (0 %)
GLD $ 219.89 $ 0.38 (0.17 %)
$ 7.9
-- x --
-- x --
-- - --
$ 1.50 - $ 21.90
1,100
na
na
nm
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 this-psychedelics-company-begins-trading-on-nasdaq-with-75m-offering-then-reverse-stock-split

Psychedelics biotech firm Clearmind Medicine Inc.

 psychedelics-biotechs-clearmind-and-mydecine-share-consolidation-and-subscription-agreements

In connection with recent stock splits, psychedelics biotech Clearmind Medicine Inc.

 scisparc-and-clearmind-partnership-yields-3rd-patent-application-for-the-treating-of-obesity-and-metabolic-syndromes

SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisiona...

Core News & Articles

TEL AVIV, Israel, Sept. 22, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) (“Company” or “SciSparc”), a specialty clinica...

 psychedelic-based-cocaine-addiction-treatment-study-showing-positive-results-this-is-what-we-know

Israeli-Canadian biotech psychedelics developer Clearmind Medicine Inc. (OTC Pink: CMNDF) together with clinical-stage cannabin...

Core News & Articles

Results indicate significant decrease in cocaine craving in a sub-group that received the treatment TEL AVIV, Israel, Aug. 24,...

 psyched-christies-launches-nft-collection-supporting-psychedelic-science-origins-listing-on-cse-gives-retail-investors-access-to-private-companies

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

 scisparc--clearmind-medicine-team-up-on-patent-for-psychedelic-combination-to-treat-cocaine-addiction

SciSparc Ltd. (NASDAQ: SPRC) collaboration with Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) resulted in the fil...

Core News & Articles

Clearmind Medicine Inc.

 patent-for-psychedelic-based-alcohol-substitute-approved-in-india-produced-by-clearmind-medicine

India's Office of the Controller-General of Patents, Designs and Trademarks granted approval for a new compound created by ...

 high-hopes-for-alcohol-use-disorder-treatment-clearminds-successful-pre-ind-meeting-with-the-fda

The meeting, which took place on May 18 between the psychedelic pharmaceutical biotech company Clearmind Medicine Inc. (CMNDF) ...

 psyched-medical-psychedelics-in-davos-canadian-sen-does-psychedelics-eiventures--mycotopia-to-merge-into-383m-company

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

 psychedelic-treatment-for-alcoholism-clearmind-medicine-and-scisparc-collaboration-yields-positive-results

Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) a biotech company focused on discovery and development of novel psy...

Core News & Articles

Clearmind Medicine Inc. (CSE:CMND, OTC:CMNDF, FSE: CWY0)))) ("Clearmind" or the "Company"), a biotech company f...

 clearmind-positive-preclinical-evidence-for-flagship-psychedelic-molecule-looks-to-human-trials-before-year-end

Psychedelics biotech company Clearmind Medicine Inc.

 psyched-compass-atai-and-mindmed-release-q1-earnings-phase-3-mdma-trial-closer-to-completion-enveric-splits-into-two-companies

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports fo...

 has-clearmind-developed-a-psychedelics-based-drug-that-can-treat-alcoholism-the-fda-is-interested

On Wednesday, May 18, Clearmind Medicine Inc. (OTC Pink: CMNDF) will meet with the Center for Drug Evaluation and Research (CDE...

Core News & Articles

Results demonstrated that combining SciSparc's CannAmide™ with Clearmind's MEAI has the potential to reduce alcohol con...